ChanEx gene therapy (Oxford Biomedica)

ChanEx基因疗法

Report date: 2022/01/14 13:23:58

Base Information

Drug NameChanEx gene therapy (Oxford Biomedica)
Drug Alias NameChanEx
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionChloride channel modulators
TargetsChloride channel
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOxford Biomedica
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxford Biomedica
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A